$9.74
-0.14-1.42%
At Close: -
$9.74
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Nevro (NYSE:NVRO) Stock, Analyst Ratings, Price Targets, Forecasts
Nevro Corp has a consensus price target of $36.11 based on the ratings of 23 analysts. The high is $150 issued by Morgan Stanley on August 5, 2021. The low is $8.2 issued by Citigroup on July 10, 2024. The 3 most-recent analyst ratings were released by Truist Securities, Morgan Stanley, and Citigroup on July 16, 2024, July 15, 2024, and July 10, 2024, respectively. With an average price target of $9.07 between Truist Securities, Morgan Stanley, and Citigroup, there's an implied -6.91% downside for Nevro Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Morgan Stanley
Citigroup
Canaccord Genuity
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Nevro
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | Buy Now | 2.67% | Truist Securities | Richard Newitter | $11 → $10 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | -7.6% | Morgan Stanley | Cecilia Furlong | $14 → $9 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | -15.81% | Citigroup | Joanne Wuensch | $9 → $8.2 | Maintains | Sell | Get Alert |
| 05/22/2024 | Buy Now | -7.6% | Citigroup | Joanne Wuensch | $13.5 → $9 | Downgrade | Neutral → Sell | Get Alert |
| 05/08/2024 | Buy Now | 12.94% | Canaccord Genuity | William Plovanic | $17 → $11 | Maintains | Hold | Get Alert |
| 05/08/2024 | Buy Now | 33.47% | Wells Fargo | Nathan Treybeck | $14 → $13 | Maintains | Equal-Weight | Get Alert |
| 05/08/2024 | Buy Now | 23.2% | Piper Sandler | Adam Maeder | $15 → $12 | Maintains | Underweight | Get Alert |
| 04/15/2024 | Buy Now | 64.27% | RBC Capital | Shagun Singh | $18 → $16 | Maintains | Sector Perform | Get Alert |
| 04/11/2024 | Buy Now | 64.27% | Mizuho | Anthony Petrone | $20 → $16 | Maintains | Neutral | Get Alert |
| 04/08/2024 | Buy Now | 43.74% | Wells Fargo | Larry Biegelsen | $17 → $14 | Maintains | Equal-Weight | Get Alert |
| 04/03/2024 | Buy Now | 64.27% | Citigroup | Joanne Wuensch | $18 → $16 | Maintains | Neutral | Get Alert |
| 02/22/2024 | Buy Now | — | Oppenheimer | Suraj Kalia | — | Downgrade | Outperform → Perform | Get Alert |
| 02/22/2024 | Buy Now | 74.54% | Wells Fargo | Lawrence Biegelsen | $20 → $17 | Maintains | Equal-Weight | Get Alert |
| 02/22/2024 | Buy Now | 95.07% | Baird | Mike Polark | $23 → $19 | Maintains | Neutral | Get Alert |
| 01/12/2024 | Buy Now | 105.34% | RBC Capital | Shagun Singh | $23 → $20 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/22/2023 | Buy Now | 136.14% | Truist Securities | Richard Newitter | $22 → $23 | Maintains | Hold | Get Alert |
| 12/21/2023 | Buy Now | 136.14% | Canaccord Genuity | William Plovanic | → $23 | Downgrade | Buy → Hold | Get Alert |
| 12/01/2023 | Buy Now | 136.14% | RBC Capital | Shagun Singh | → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 11/03/2023 | Buy Now | 74.54% | Truist Securities | Richard Newitter | $18.5 → $17 | Maintains | Hold | Get Alert |
| 11/02/2023 | Buy Now | 84.8% | JP Morgan | Robbie Marcus | $23 → $18 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | 54% | Piper Sandler | Adam Maeder | $24 → $15 | Maintains | Underweight | Get Alert |
| 11/02/2023 | Buy Now | 84.8% | Morgan Stanley | Cecilia Furlong | $23 → $18 | Maintains | Equal-Weight | Get Alert |
| 08/21/2023 | Buy Now | 115.61% | Citigroup | Joanne Wuensch | $24 → $21 | Maintains | Neutral | Get Alert |
| 08/17/2023 | Buy Now | 238.81% | RBC Capital | Shagun Singh | → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 08/03/2023 | Buy Now | 156.67% | Truist Securities | Richard Newitter | $27 → $25 | Maintains | Hold | Get Alert |
| 08/02/2023 | Buy Now | 485.22% | Canaccord Genuity | William Plovanic | $68 → $57 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 136.14% | JP Morgan | Robbie Marcus | $28 → $23 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | 238.81% | RBC Capital | Shagun Singh | $39 → $33 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | 136.14% | Morgan Stanley | Cecilia Furlong | $29 → $23 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | 136.14% | Wells Fargo | Lawrence Biegelsen | $27 → $23 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | 259.34% | Oppenheimer | Suraj Kalia | $40 → $35 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | 136.14% | Baird | Mike Polark | $26 → $23 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | 310.68% | JMP Securities | David Turkaly | $75 → $40 | Maintains | Outperform | Get Alert |
| 07/19/2023 | Buy Now | 177.21% | Truist Securities | Richard Newitter | $30 → $27 | Maintains | Hold | Get Alert |
| 07/19/2023 | Buy Now | 166.94% | Baird | Mike Polark | → $26 | Initiates | → Neutral | Get Alert |
| 06/28/2023 | Buy Now | 187.47% | JP Morgan | Robbie Marcus | $40 → $28 | Maintains | Neutral | Get Alert |
| 06/07/2023 | Buy Now | 177.21% | Citigroup | Joanne Wuensch | $37 → $27 | Maintains | Neutral | Get Alert |
| 06/06/2023 | Buy Now | 310.68% | RBC Capital | Shagun Singh | → $40 | Reiterates | → Outperform | Get Alert |
| 06/06/2023 | Buy Now | 208.01% | Truist Securities | Richard Newitter | $32 → $30 | Maintains | Hold | Get Alert |
| 06/06/2023 | Buy Now | 598.15% | Canaccord Genuity | William Plovanic | $76 → $68 | Maintains | Buy | Get Alert |
| 06/06/2023 | Buy Now | 177.21% | Wells Fargo | Lawrence Biegelsen | $37 → $27 | Maintains | Equal-Weight | Get Alert |
| 05/31/2023 | Buy Now | 197.74% | Morgan Stanley | Cecilia Furlong | $40 → $29 | Maintains | Equal-Weight | Get Alert |
| 05/31/2023 | Buy Now | 310.68% | RBC Capital | Shagun Singh | → $40 | Initiates | → Outperform | Get Alert |
| 05/18/2023 | Buy Now | 228.54% | Truist Securities | Richard Newitter | $40 → $32 | Maintains | Hold | Get Alert |
| 05/15/2023 | Buy Now | 310.68% | Oppenheimer | Suraj Kalia | → $40 | Upgrade | Perform → Outperform | Get Alert |
| 04/27/2023 | Buy Now | 279.88% | Citigroup | Joanne Wuensch | $40 → $37 | Maintains | Neutral | Get Alert |
| 04/27/2023 | Buy Now | 249.08% | Piper Sandler | Adam Maeder | $37 → $34 | Maintains | Underweight | Get Alert |
| 04/27/2023 | Buy Now | 310.68% | Morgan Stanley | Cecilia Furlong | $46 → $40 | Maintains | Equal-Weight | Get Alert |
| 04/27/2023 | Buy Now | 670.02% | JMP Securities | David Turkaly | → $75 | Reiterates | → Market Outperform | Get Alert |
| 04/17/2023 | Buy Now | 310.68% | Truist Securities | Richard Newitter | $42 → $40 | Maintains | Hold | Get Alert |
| 04/14/2023 | Buy Now | 310.68% | Mizuho | Anthony Petrone | → $40 | Initiates | → Neutral | Get Alert |
| 04/13/2023 | Buy Now | 310.68% | Mizuho | Anthony Petrone | → $40 | Initiates | → Neutral | Get Alert |
| 02/06/2023 | Buy Now | 639.22% | Canaccord Genuity | William Plovanic | $67 → $72 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | 279.88% | Piper Sandler | Adam Maeder | $38 → $37 | Maintains | Underweight | Get Alert |
| 01/17/2023 | Buy Now | 310.68% | Citigroup | Joanna Wiensch | → $40 | Downgrade | Buy → Neutral | Get Alert |
| 01/11/2023 | Buy Now | 279.88% | Wells Fargo | Lawrence Biegelsen | $43 → $37 | Maintains | Equal-Weight | Get Alert |
| 01/06/2023 | Buy Now | 372.28% | Morgan Stanley | Cecilia Furlong | $49 → $46 | Maintains | Equal-Weight | Get Alert |
| 01/06/2023 | Buy Now | 290.14% | Piper Sandler | Adam Maeder | $42 → $38 | Downgrade | Neutral → Underweight | Get Alert |
| 12/20/2022 | Buy Now | 587.89% | Canaccord Genuity | William Plovanic | $41 → $67 | Upgrade | Hold → Buy | Get Alert |
| 12/20/2022 | Buy Now | 320.94% | Truist Securities | Richard Newitter | $45 → $41 | Maintains | Hold | Get Alert |
| 12/12/2022 | Buy Now | 341.48% | Wells Fargo | Larry Biegelsen | $66 → $43 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/03/2022 | Buy Now | 310.68% | JP Morgan | Robbie Marcus | $50 → $40 | Maintains | Neutral | Get Alert |
| 11/03/2022 | Buy Now | 331.21% | Piper Sandler | Adam Maeder | $45 → $42 | Maintains | Neutral | Get Alert |
| 10/12/2022 | Buy Now | 218.28% | Jefferies | Matthew Taylor | → $31 | Initiates | → Underperform | Get Alert |
| 10/11/2022 | Buy Now | 403.08% | Morgan Stanley | Cecilia Furlong | $54 → $49 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | Buy Now | 454.41% | Morgan Stanley | David Lewis | $55 → $54 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | Buy Now | 782.96% | Wells Fargo | Lawrence Biegelsen | $90 → $86 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | 362.01% | Piper Sandler | Adam Maeder | $64 → $45 | Maintains | Neutral | Get Alert |
| 06/07/2022 | Buy Now | 464.68% | Morgan Stanley | David Lewis | $74 → $55 | Maintains | Equal-Weight | Get Alert |
| 05/26/2022 | Buy Now | 875.36% | JMP Securities | David Turkaly | $125 → $95 | Maintains | Market Outperform | Get Alert |
| 05/17/2022 | Buy Now | 598.15% | Citigroup | Joanne Wuensch | $78 → $68 | Maintains | Buy | Get Alert |
| 05/05/2022 | Buy Now | 659.75% | Morgan Stanley | David Lewis | $76 → $74 | Maintains | Equal-Weight | Get Alert |
| 05/05/2022 | Buy Now | 557.08% | Piper Sandler | Adam Maeder | $65 → $64 | Maintains | Neutral | Get Alert |
| 04/06/2022 | Buy Now | 557.08% | Wolfe Research | Mike Polark | → $64 | Initiates | → Underperform | Get Alert |
| 02/25/2022 | Buy Now | 680.29% | Morgan Stanley | David Lewis | $100 → $76 | Maintains | Equal-Weight | Get Alert |
| 02/24/2022 | Buy Now | 824.02% | Wells Fargo | Lawrence Biegelsen | $116 → $90 | Maintains | Overweight | Get Alert |
| 02/24/2022 | Buy Now | 772.69% | SVB Leerink | Danielle Antalffy | $105 → $85 | Maintains | Outperform | Get Alert |
| 02/24/2022 | Buy Now | 567.35% | Piper Sandler | Adam Maeder | $92 → $65 | Maintains | Neutral | Get Alert |
| 01/12/2022 | Buy Now | 895.89% | Canaccord Genuity | William Plovanic | $118 → $97 | Maintains | Hold | Get Alert |
| 01/07/2022 | Buy Now | 926.69% | Morgan Stanley | Cecilia Furlong | $140 → $100 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/21/2021 | Buy Now | 875.36% | Truist Securities | Kaila Krum | $105 → $95 | Maintains | Hold | Get Alert |
| 12/06/2021 | Buy Now | 1090.97% | Wells Fargo | Lawrence Biegelsen | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/09/2021 | Buy Now | 978.03% | Truist Securities | Kaila Krum | — | Downgrade | Buy → Hold | Get Alert |
| 11/09/2021 | Buy Now | 1090.97% | Wells Fargo | Lawrence Biegelsen | — | Maintains | Equal-Weight | Get Alert |
| 11/09/2021 | Buy Now | 1214.17% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
| 10/06/2021 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
| 08/05/2021 | Buy Now | 1440.04% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 08/05/2021 | Buy Now | 1049.9% | Canaccord Genuity | William Plovanic | — | Downgrade | Buy → Hold | Get Alert |
| 08/05/2021 | Buy Now | 1542.71% | JMP Securities | David Turkaly | — | Maintains | Market Outperform | Get Alert |
| 08/05/2021 | Buy Now | 1152.57% | Wells Fargo | Lawrence Biegelsen | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/05/2021 | Buy Now | 1183.37% | Citigroup | Joanne Wuensch | — | Downgrade | Buy → Neutral | Get Alert |
| 08/05/2021 | Buy Now | 1409.24% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
| 08/05/2021 | Buy Now | 1183.37% | Piper Sandler | Adam Maeder | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/05/2021 | Buy Now | — | William Blair | Margaret Kaczor | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Nevro (NVRO) stock?
The latest price target for Nevro (NYSE:NVRO) was reported by Truist Securities on July 16, 2024. The analyst firm set a price target for $10.00 expecting NVRO to rise to within 12 months (a possible 2.67% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nevro (NVRO)?
The latest analyst rating for Nevro (NYSE:NVRO) was provided by Truist Securities, and Nevro maintained their hold rating.
When was the last upgrade for Nevro (NVRO)?
The last upgrade for Nevro Corp happened on May 15, 2023 when Oppenheimer raised their price target to $40. Oppenheimer previously had a perform for Nevro Corp.
When was the last downgrade for Nevro (NVRO)?
The last downgrade for Nevro Corp happened on May 22, 2024 when Citigroup changed their price target from $13.5 to $9 for Nevro Corp.
When is the next analyst rating going to be posted or updated for Nevro (NVRO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nevro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nevro was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
Is the Analyst Rating Nevro (NVRO) correct?
While ratings are subjective and will change, the latest Nevro (NVRO) rating was a maintained with a price target of $11.00 to $10.00. The current price Nevro (NVRO) is trading at is $9.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.